Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 335

The DOI matches its Crossref record; 189 of the 189 references it cites were found in a registry or an index.

Glucose Metabolism in Cardiac Hypertrophy and Heart Failure

Open access
Tran, Diem H., Wang, Zhao V.·2019·Journal of the American Heart Association

Abstract

H eart failure is one of the leading causes of death worldwide and has been singled out as an emerging epidemic. With a 5-year survival rate of 50%, heart failure poses a tremendous burden on our economic and healthcare system. Despite extensive interests and paramount clinical needs, our understanding of heart failure remains incomplete. As a consequence, there is currently no cure. Hypertension is one of the most important risk factors of heart failure. Under high blood pressure, cardiac ventricular wall stress is mounted. According to Laplace’s law, an increase in cardiac wall thickness can effectively ameliorate wall stress. This so-called concentric cardiac growth is achieved by upregulation of sarcomere biosynthesis and enlargement of individual cardiac myocytes attributed to limited replicative capacity in the adult heart. In response to persistent stress, however, this once adaptive hypertrophic growth may progress into decompensation and heart failure. Over the past few decades, numerous signaling molecules and pathways have been identified in cardiac hypertrophic growth and heart failure. These processes involve extensive cardiac remodeling in metabolism, structure, and electrophysiology. Growing evidence indicates that metabolic remodeling precedes most, if not all, other pathological alterations and likely plays an essential role in cardiac hypertrophy and heart failure. Ischemic heart disease is another critical contributing factor to heart failure. Patients surviving myocardial infarction (MI) may undergo extensive pathological remodeling in the heart with major metabolic derangements. Here, we review recent findings of cardiac metabolic changes in response to hemodynamic stress and cardiac ischemia with a focus on glucose utilization. We also discuss potential therapeutic targets from carbohydrate metabolic pathways to tackle this devastating heart disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/jaha.119.012673

Cites

189 of 189 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 189 references

Cited by

See all 335

Metadata

Authors
Tran, D. H., & Wang, Z. V.
Venue
Journal of the American Heart Association
Published
2019-06-18
Volume
8
Issue
12
Pages
e012673-e012673
ISSN
2047-9980 (ISSN-L)
OpenAlex
W2949802136
Cited by
335
References
189
FWCI
18.42
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glucose Metabolism in Cardiac Hypertrophy and Heart Failure. https://app.cochat.ai/papers/10.1161/jaha.119.012673
The paper
Tran, D. H., & Wang, Z. V. (2019). Glucose Metabolism in Cardiac Hypertrophy and Heart Failure. Journal of the American Heart Association. https://doi.org/10.1161/jaha.119.012673

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.